Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	36	non-cytoplasmic
37	56	transmembrane
57	67	cytoplasmic
68	86	transmembrane
87	106	non-cytoplasmic
107	136	transmembrane
137	147	cytoplasmic
148	172	transmembrane
173	183	non-cytoplasmic
184	208	transmembrane
209	227	cytoplasmic
228	254	transmembrane
255	259	non-cytoplasmic
260	275	transmembrane
276	293	cytoplasmic
294	314	transmembrane
315	333	non-cytoplasmic
334	362	transmembrane
363	371	cytoplasmic
372	400	transmembrane
401	425	non-cytoplasmic
426	447	transmembrane
448	503	cytoplasmic

Input:
>AZOBR_RS20015
MAAFLIENMAPLMFAALVLFLLMGFPVAFALAANGLLFGLIGIELGLLTPALFQALPERV
FGIMRNDTLLAIPFFTFMGLILERSGMAEDLLDTVGQLFGPLRGGLAYAVIFVGALLAAT
TGVVAASVISMGLISLPIMLRYGYDRRLASGVIAASGTLAQIIPPSLVLIILADQLGRSV
GDMYAGALVPGLVLTGLYAGYILVVSIVRPEFTPALPPEARSLRGFQLLFRVLTSLVPPL
VLIFLVLGTIFIGIATPTEGGAMGAAGAMILALMKRQLSWSLMRQAMDTTAKLSSFVIFI
LIGSTVFGLVFRAVNGDLWVEHLLTSLPGGELGFLIVVNIMVFLLAFFLDFFELAFIIVP
LLAPVAEKLGIDLIWFGVLLGVNMQTSFMHPPFGFALFFLRSVAPREDYKDKITGKIIKK
ITTGQIYWGAVPFVCIQLIMVALVIMFPEMVFSGLDRGEPIDLDNVKIEIPAFDSGEPPP
PFGAPEQPAEDPNADLMRQLQGK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server